Moberg Pharma AB (publ) (MOB) — Cash Flow Reinvestment Rate

Latest as of December 2025: 1.00x

Moberg Pharma AB (publ) (MOB) has a Cash Flow Reinvestment Rate of 1.00x as of December 2025, reinvesting Skr1.52 Million (capex Skr1.52 Million ) from operating cash flow of Skr1.52 Million. See Moberg Pharma AB (publ) (MOB) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

1.00x

(Capex + Investments) / Operating CF

Total Reinvested

Skr1.52 Million

Capex + Investments

Operating Cash Flow

Skr1.52 Million

SEK

Capital Expenditures

Skr1.52 Million

SEK

Moberg Pharma AB (publ) Cash Flow Reinvestment Rate (2012–2019)

Historical reinvestment intensity for Moberg Pharma AB (publ) across 6 annual periods. For the full cash flow conversion analysis, see MOB operating cash flow.

Annual Cash Flow Reinvestment Rate for Moberg Pharma AB (publ) (2012–2019)

Year-by-year capital reinvestment analysis for Moberg Pharma AB (publ). See Moberg Pharma AB (publ) (MOB) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (SEK)	Operating CF	Capex	YoY Change
2019	0.73x	Skr2.87 Million	Skr3.95 Million	Skr2.87 Million	▼ -67.9%
2018	2.26x	Skr167.28 Million	Skr73.89 Million	Skr83.64 Million	▲ +209.6%
2017	0.73x	Skr39.35 Million	Skr53.82 Million	Skr19.68 Million	▼ -48.8%
2015	1.43x	Skr43.88 Million	Skr30.72 Million	Skr43.88 Million	▲ +217.5%
2014	0.45x	Skr7.27 Million	Skr16.16 Million	Skr7.27 Million	▲ +576.8%
2012	0.07x	Skr630.00K	Skr9.48 Million	Skr630.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow